Tofacitinib for managing granuloma formation after dermal filler injection: three case reports and literature review

CONCLUSION: This report emphasizes the effectiveness of JAK inhibitors in treating granulomas caused by filler injections. Recent advancements in understanding the underlying mechanisms of granulomatous reactions have paved the way for JAK inhibitors to be regarded as a promising treatment choice. However, further research is necessary to fully assess the safety and long-term effectiveness of using tofacitinib for granuloma treatment.PMID:38632962 | DOI:10.1080/09546634.2024.2338281

Source: Journal of Dermatological Treatment - April 18, 2024 Category: Dermatology Authors: Jieyi Wang Zhuoxuan Chen Lin Wu Yan Liao Bo Yu Source Type: research